Home/Filings/4/0001209191-20-012314
4//SEC Filing

MANN BRUCE 4

Accession 0001209191-20-012314

CIK 0001173489other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 9:59 PM ET

Size

37.6 KB

Accession

0001209191-20-012314

Insider Transaction Report

Form 4
Period: 2020-02-20
MANN BRUCE
Director
Transactions
  • Tax Payment

    Common Stock

    2020-02-20$35.16/sh7,013$246,5775,987 total
  • Exercise/Conversion

    Common Stock

    2020-02-20$19.43/sh+6,500$126,2956,500 total
  • Sale

    Common Stock

    2020-02-20$35.16/sh5,540$194,7869,185 total
  • Sale

    Common Stock

    2020-02-20$35.16/sh3,250$114,27019,357 total
  • Sale

    Common Stock

    2020-02-20$35.16/sh4,632$162,86114,725 total
  • Exercise/Conversion

    Common Stock

    2020-02-20$27.17/sh+9,750$264,9089,750 total
  • Sale

    Common Stock

    2020-02-20$35.16/sh2,368$83,2590 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-02-2013,0000 total
    Exercise: $14.77Exp: 2024-06-30Common Stock (0 underlying)
  • Exercise/Conversion

    Common Stock

    2020-02-20$19.36/sh+13,000$251,68013,000 total
  • Sale

    Common Stock

    2020-02-20$35.16/sh2,981$104,8120 total
  • Sale

    Common Stock

    2020-02-20$35.16/sh5,987$210,5030 total
  • Exercise/Conversion

    Common Stock

    2020-02-20$14.77/sh+13,000$192,01013,000 total
  • Tax Payment

    Common Stock

    2020-02-20$35.16/sh5,350$188,1067,560 total
  • Tax Payment

    Common Stock

    2020-02-20$35.16/sh3,519$123,7282,981 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-02-2013,0000 total
    Exercise: $19.36Exp: 2023-06-30Common Stock (0 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-02-206,5000 total
    Exercise: $19.43Exp: 2025-01-07Common Stock (0 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-02-209,7500 total
    Exercise: $27.17Exp: 2026-01-07Common Stock (0 underlying)
  • Sale

    Common Stock

    2020-02-20$35.16/sh7,650$268,9740 total
  • Tax Payment

    Common Stock

    2020-02-20$35.16/sh7,382$259,5512,368 total
Footnotes (8)
  • [F1]Represents a "net exercise" of outstanding stock options. The reporting person received 7,013 shares of common stock on the net exercise of an option to purchase 13,000 shares of common stock. The reporting person forfeited 5,987 shares of common stock underlying the option in payment of the exercise price, based on the market price of CEVA common stock at the time of the option exercise on February 20, 2020 of $35.16.
  • [F2]Represents a "net exercise" of outstanding stock options. The reporting person received 5,350 shares of common stock on the net exercise of an option to purchase 13,000 shares of common stock. The reporting person forfeited 7,650 shares of common stock underlying the option in payment of the exercise price, based on the market price of CEVA common stock at the time of the option exercise on February 20, 2020 of $35.16.
  • [F3]Represents a "net exercise" of outstanding stock options. The reporting person received 3,519 shares of common stock on the net exercise of an option to purchase 6,500 shares of common stock. The reporting person forfeited 2,981 shares of common stock underlying the option in payment of the exercise price, based on the market price of CEVA common stock at the time of the option exercise on February 20, 2020 of $35.16.
  • [F4]Represents a "net exercise" of outstanding stock options. The reporting person received 7,382 shares of common stock on the net exercise of an option to purchase 9,750 shares of common stock. The reporting person forfeited 2,368 shares of common stock underlying the option in payment of the exercise price, based on the market price of CEVA common stock at the time of the option exercise on February 20, 2020 of $35.16.
  • [F5]Represents restricted stock units ("RSUs")
  • [F6]Represents 2,064 shares outstanding and 7,121 unvested RSUs.
  • [F7]The stock option was granted pursuant to the company's 2003 Director Stock Option Plan.
  • [F8]The stock option became exercisable as to 25% of the underlying shares on the first year anniversary of the grant date and 25% each year thereafter.

Issuer

CEVA INC

CIK 0001173489

Entity typeother

Related Parties

1
  • filerCIK 0001201701

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 9:59 PM ET
Size
37.6 KB